Lee Ainslie 10x Genomics, Inc. Transaction History

Maverick Capital LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $119,666 - $157,939	-822 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$134.22 - $202.37 $158,379 - $238,796	-1,180 Reduced 58.94%	822 $161,000
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $87,375 - $122,643	623 Added 45.18%	2,002 $362,000
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $174,402 - $225,742	1,379 New	1,379 $195,000

291

96.1M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.43B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.